Literature DB >> 1681748

Ultradian variations of chromogranin A in humans.

M A Takiyyuddin1, H P Neumann, J H Cervenka, B Kennedy, T Q Dinh, M G Ziegler, A D Baron, D T O'Connor.   

Abstract

Chromogranin A (CgA) is an acidic soluble protein exocytotically released from virtually all neuroendocrine secretory vesicles. Here we examined spontaneous variations in CgA and catecholamine concentrations in humans. In normal subjects, basal CgA showed no day-to-day, week-to-week, or diurnal variability. Plasma CgA had significant ultradian variation in normotensives and hypertensives, and in bilaterally adrenalectomized subjects. Gender, but not age or blood pressure, influenced CgA variations, males having fewer (P less than 0.05) peaks per 8 h. Plasma catecholamines had significant ultradian variations in both controls and bilaterally adrenalectomized subjects. Within individuals, neither basal nor peak plasma CgA correlated with catecholamines, nor was there concordance between plasma CgA and catecholamine peaks. Somatostatin, a widespread inhibitor of nonsympathoadrenal neuroendocrine secretion, diminished both the frequency and amplitude of plasma CgA peaks. Thus spontaneous variations in basal CgA are not directly linked to alterations in sympathoadrenal catecholamine secretion. Furthermore, neuroendocrine secretion at sites other than the sympathoadrenal system contributes to spontaneous variations in CgA concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681748     DOI: 10.1152/ajpregu.1991.261.4.R939

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.

Authors:  Constantin S Jianu; Reidar Fossmark; Unni Syversen; Øyvind Hauso; Helge L Waldum
Journal:  Tumour Biol       Date:  2010-05-18

2.  Chromogranin A plasma levels predict mortality in COVID-19.

Authors:  Rebecca De Lorenzo; Clara Sciorati; Giuseppe A Ramirez; Barbara Colombo; Nicola I Lorè; Annalisa Capobianco; Cristina Tresoldi; Daniela M Cirillo; Fabio Ciceri; Angelo Corti; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.240

3.  Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).

Authors:  Supranee Jitpean; Mats Stridsberg; Ann Pettersson; Odd V Höglund; Bodil Ström Holst; Ragnvi Hagman
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

4.  Catestatin and vasostatin concentrations in healthy dogs.

Authors:  Thanikul Srithunyarat; Ragnvi Hagman; Odd V Höglund; Ulf Olsson; Mats Stridsberg; Supranee Jitpean; Anne-Sofie Lagerstedt; Ann Pettersson
Journal:  Acta Vet Scand       Date:  2017-01-03       Impact factor: 1.695

5.  Circadian variations in salivary chromogranin a concentrations during a 24-hour period in dogs.

Authors:  Kazutaka Kanai; Mariko Hino; Yasutomo Hori; Ruriko Nakao; Fumio Hoshi; Naoyuki Itoh; Seiichi Higuchi
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

6.  Chromogranins can be measured in samples from cats and dogs.

Authors:  Mats Stridsberg; Ann Pettersson; Ragnvi Hagman; Christoffer Westin; Odd Höglund
Journal:  BMC Res Notes       Date:  2014-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.